Palo Alto, CALIFORNIA1 Active Studies

Substance Use Disorder Clinical Trials in Palo Alto, CALIFORNIA

Find 1 actively recruiting substance use disorder clinical trials in Palo Alto, CALIFORNIA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
952
Enrolling

Recruiting Substance Use Disorder Studies in Palo Alto

About Substance Use Disorder Clinical Trials in Palo Alto

Substance use disorder is a condition where the use of substances leads to health issues, disability, and failure to meet responsibilities. It encompasses alcohol, opioid, stimulant, and other drug addictions. Treatment includes behavioral therapy, medication-assisted treatment, and support programs.

There are currently 1 substance use disorder clinical trials recruiting participants in Palo Alto, CALIFORNIA. These studies are seeking a combined 952 participants. Research is being sponsored by VA Office of Research and Development. Clinical trial participation is free and participants receive study-related medical care at no cost.

Substance Use Disorder Clinical Trials in Palo Alto — FAQ

Are there substance use disorder clinical trials in Palo Alto?

Yes, there are 1 substance use disorder clinical trials currently recruiting in Palo Alto, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Palo Alto?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.

Are clinical trials in Palo Alto free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.

What substance use disorder treatments are being tested?

The 1 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for substance use disorder.

Data updated March 2, 2026 from ClinicalTrials.gov